SCHEMBL7168931

SCHEMBL7168931

Oc1ccccc1OCc1ncc2ccccc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.51
▸ MAPT P10636 3/20 0.51
▸ HPGD P15428 2/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ GAA P10253 5/20 0.44
▸ LMNA P02545 3/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ APP P05067 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.41
▸ CYSLTR1 Q9Y271 1/20 0.38
▸ HTT P42858 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ PDE10A Q9Y233 1/20 0.37
▸ STAT3 P40763 2/20 0.37
▸ EGFR P00533 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ ALOX5 P09917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7501938 0.82 PDE10A (0.40) SMN1; SMN2MAPTLMNACYSLTR1HTT
SCHEMBL10669295 0.77 CYSLTR1 (0.57) SMN1; SMN2CYSLTR1NPC1RAB9APDE10A
SCHEMBL6582909 0.76 CYSLTR1 (0.61) SMN1; SMN2MAPTHPGDHSD17B10CYSLTR1
SCHEMBL30824487 0.75 TSHR (0.41) SMN1; SMN2CYSLTR1HTTKDM4EPDE10A
SCHEMBL6597830 0.72 SORD (0.47) MAPTHPGDGAAALDH1A1CYSLTR1
SCHEMBL8112158 0.72 PDE10A (0.47) SMN1; SMN2LMNACYSLTR1NPC1RAB9A
SCHEMBL27595473 0.72 SMN1; SMN2 (0.51) SMN1; SMN2MAPTGAALMNACYSLTR1
SCHEMBL10430121 0.72 MAPT (0.42) MAPTGAAALDH1A1CYSLTR1KDM4E
SCHEMBL28840069 0.71 ALDH1A1 (0.38) SMN1; SMN2GAAALDH1A1CYSLTR1KDM4E
SCHEMBL9688234 0.71 CYSLTR2 (0.41) SMN1; SMN2MAPTGAALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345927-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-09-24 — — EP disclosed
WO-2002062789-A1 PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-08-15 — — WO disclosed
Send feedback